Axsome Therapeutics, Inc. (LON:0HKF)
London · Delayed Price · Currency is GBP · Price in USD 155.62
+2.41 (1.58%)
At close: Dec 24, 2025
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of 5.68 billion as of December 26, 2025. Its market cap has increased by 51.29% in one year.
Market Cap
5.68B
Enterprise Value
5.60B
Revenue
417.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
155.62
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from 95.66M to 5.68B, an increase of 5,841.70%. That is a compound annual growth rate of 49.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 5.68B | 73.55% |
| Dec 31, 2024 | 3.28B | 10.77% |
| Dec 29, 2023 | 2.96B | 6.36% |
| Dec 30, 2022 | 2.78B | 164.34% |
| Dec 31, 2021 | 1.05B | -52.81% |
| Dec 31, 2020 | 2.23B | -22.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.05B |
| GSK plc | 72.45B |
| Haleon | 33.16B |
| Smith & Nephew | 10.37B |
| Convatec Group | 4.64B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 1.71B |
| HUTCHMED (China) | 1.69B |